AU2002335843A1 - Use of ace inhibitors for reducing type 2 diabetes in high risk patients - Google Patents

Use of ace inhibitors for reducing type 2 diabetes in high risk patients

Info

Publication number: AU2002335843A1
Authority: AU; Australia
Prior art keywords: diabetes; high risk; ace inhibitors; risk patients; reducing type
Prior art date: 2001-10-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002335843A

Inventor

Salim Yusuf

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

King Pharmaceuticals Research and Development Inc

Original Assignee

King Pharmaceuticals Research and Development Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-17

Filing date

2002-10-17

Publication date

2003-04-28

2002-10-17 Application filed by King Pharmaceuticals Research and Development Inc filed Critical King Pharmaceuticals Research and Development Inc

2003-04-28 Publication of AU2002335843A1 publication Critical patent/AU2002335843A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

AU2002335843A 2001-10-17 2002-10-17 Use of ace inhibitors for reducing type 2 diabetes in high risk patients Abandoned AU2002335843A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US34449501P	2001-10-17	2001-10-17
US60/344,495		2001-10-17
PCT/US2002/033213 WO2003032965A2 (en)	2001-10-17	2002-10-17	Use of ace inhibitors for reducing type 2 diabetes in high risk patients

Publications (1)

Publication Number	Publication Date
AU2002335843A1 true AU2002335843A1 (en)	2003-04-28

Family

ID=23350759

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002335843A Abandoned AU2002335843A1 (en)	2001-10-17	2002-10-17	Use of ace inhibitors for reducing type 2 diabetes in high risk patients

Country Status (7)

Country	Link
EP (1)	EP1438043A2 (en)
JP (1)	JP2005531492A (en)
AU (1)	AU2002335843A1 (en)
CA (1)	CA2463682A1 (en)
IL (1)	IL161388A0 (en)
MX (1)	MXPA04003022A (en)
WO (2)	WO2003032965A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2458288A1 (en) *	2003-03-11	2004-09-11	Institut De Cardiologie De Montreal / Montreal Heart Institute	Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure
US20050065184A1 (en) *	2003-08-29	2005-03-24	Aaipharma Inc.	Method of reducing the risk of oxidative stress
MX2009002091A (en) *	2006-08-28	2009-03-09	Sanofi Aventis Deutschland	Methods of lowering glucose levels.
AP2015008789A0 (en)	2013-03-14	2015-10-31	Cytokinetics Inc	Heterocyclic compounds and their uses
US10159667B2 (en) *	2013-06-26	2018-12-25	Dong-A St Co., Ltd	Composition containing a DPP-IV inhibitor for preventing or treating renal diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0331014A3 (en) *	1988-03-02	1991-10-23	THERA - Patent Verwaltungs-GmbH	Use of ace inhibitors in diabetes prophylaxis
DE4308504A1 (en) *	1993-03-18	1994-09-22	Knoll Ag	New use of a combination of verapamil and trandolapril
SE9903028D0 (en) *	1999-08-27	1999-08-27	Astra Ab	New use
EE05670B1 (en) *	1999-08-30	2013-08-15	Aventis Pharma Deutschland Gmbh	Ramipril for the 'financing of cardiovascular events

2002
- 2002-10-17 IL IL16138802A patent/IL161388A0/en unknown
- 2002-10-17 WO PCT/US2002/033213 patent/WO2003032965A2/en not_active Ceased
- 2002-10-17 WO PCT/EP2002/011636 patent/WO2003032963A2/en not_active Ceased
- 2002-10-17 AU AU2002335843A patent/AU2002335843A1/en not_active Abandoned
- 2002-10-17 JP JP2003535767A patent/JP2005531492A/en not_active Withdrawn
- 2002-10-17 EP EP02790295A patent/EP1438043A2/en not_active Withdrawn
- 2002-10-17 MX MXPA04003022A patent/MXPA04003022A/en unknown
- 2002-10-17 CA CA002463682A patent/CA2463682A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2463682A1 (en)	2003-04-24
EP1438043A2 (en)	2004-07-21
WO2003032965A3 (en)	2003-11-27
IL161388A0 (en)	2004-09-27
MXPA04003022A (en)	2004-07-05
WO2003032963A2 (en)	2003-04-24
WO2003032965A2 (en)	2003-04-24
JP2005531492A (en)	2005-10-20
WO2003032963A3 (en)	2003-12-24

Similar Documents

Publication	Publication Date	Title
AU2001259758A1 (en)	2001-11-26	Interleukin-1 inhibitors in the treatment of diseases
AU2002339157A1 (en)	2003-05-26	Inhibitors of the notch signalling pathway for use in the treatment of cancer
AU2002326600A1 (en)	2003-02-24	Side-exit catheter and method for its use
AUPP609198A0 (en)	1998-10-15	Use of non-peptidyl compounds for the treatment of insulin related ailments
AU2003223579A1 (en)	2003-11-03	Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2002248319A1 (en)	2002-08-12	Pharmaceutical composition for the prevention and treatment of scar tissue
AU2003279442A1 (en)	2004-04-23	2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003201071A1 (en)	2003-07-30	Stable pharmaceutical compositions comprising ace inhibitor(s)
AU2002337913A1 (en)	2003-04-28	Glycosulfopeptide inhibitors and methods of use thereof
AU2002338734A1 (en)	2003-07-03	Use of phosphorodiesterase IV inhibitors
AU2002335843A1 (en)	2003-04-28	Use of ace inhibitors for reducing type 2 diabetes in high risk patients
AU1039801A (en)	2001-05-08	Compounds and their use as cysteine protease inhibitors
AU2003242755A1 (en)	2004-01-23	Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors
AU2002327440A1 (en)	2003-03-10	Treatment of type i diabetes
AU2003231279A1 (en)	2003-11-17	Prevention and treatment of type 2 diabetes
AU2003281176A1 (en)	2004-02-02	Medicinal composition for mitigating blood lipid or lowering blood homocystein
AU7653600A (en)	2001-04-30	Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU2003280393A1 (en)	2004-05-04	Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors
AU2002342715A1 (en)	2002-11-25	Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
AU2003240446A1 (en)	2003-10-13	Use of mob-5 in pain
AU2003260515A1 (en)	2004-03-03	Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents
AU2003216954A1 (en)	2003-10-13	Treatment of dependence and dependence related withdrawal symptoms
AU2002245598A1 (en)	2002-09-19	Administration of sleep restorative agents
HK1072560A (en)	2005-09-02	Use of thio-oxindole derivatives in treatment of hormone-related conditions
HK1070827A (en)	2005-06-30	Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions

Legal Events

Date	Code	Title	Description
2004-07-01	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase